HEMO-GE.ApS

CVR 39076322 · Private limited company (ApS) · Active · Low risk

HEMO-GE.ApS is a Private limited company (ApS), founded on , based in Rudkøbing. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 4.3m and a net result of DKK 91k. CEO: Henrik Graakjær Eriksen.

Bankruptcy risk for HEMO-GE.ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 6% of active Danish companies

Lowest riskHighest risk

Increases the risk

Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Loss for the yearNo · bankruptcy rate 5.3%0.60×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
39076322
Status
Active
Company type
Private limited company (ApS)
Founded
(9 years)
Address
Simmerbølle Kirkevej 17
5900 Rudkøbing
Municipality
Langeland
Industry
Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 50k
Auditor
REVISION &amp; RÅD, Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 8
Missing annual reportNo
Negative equityNo
Equity ratio97.0%
Current ratio3,350%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -6,000DKK -5,711
Net profitDKK 91kDKK 96k
EquityDKK 4.3mDKK 4.4m
Total assetsDKK 4.5mDKK 4.4m
CashDKK 113k–
Short-term debtDKK 133k–
Tax owedDKK 26k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · REVISION &amp; RÅD, Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025125
1 Jan 2024 – 31 Dec 2024121
1 Jan 2023 – 31 Dec 2023127
1 Jan 2022 – 31 Dec 2022166
1 Jan 2021 – 31 Dec 2021139
1 Jul 2019 – 30 Jun 2020153
1 Jul 2018 – 30 Jun 2019137
1 Jul 2017 – 30 Jun 2018151

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOHenrik Graakjær EriksenCurrent
Owner (100%)Henrik Graakjær EriksenCurrent
AuditorLLM STATSAUTORISERET REVISIONSAKTIESELSKAB

The CEOs' other companies

Henrik Graakjær Eriksen – 3 other companies

Address history (0 moves)

Simmerbølle Kirkevej 17, 5900 Rudkøbing

Other companies at the same address

Similar companies in Langeland

Questions and answers about HEMO-GE.ApS

Has HEMO-GE.ApS gone bankrupt?

No, HEMO-GE.ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of HEMO-GE.ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of HEMO-GE.ApS?

Henrik Graakjær Eriksen is the CEO of HEMO-GE.ApS.

Who is the auditor of HEMO-GE.ApS?

HEMO-GE.ApS most recently used REVISION &amp; RÅD, Statsautoriseret Revisionspartnerselskab.

When was HEMO-GE.ApS founded?

HEMO-GE.ApS was founded on 25 October 2017.

What is the equity of HEMO-GE.ApS?

Equity was DKK 4.3m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.